Interview with Ulrich Eggert, Managing Director, Astellas Pharma Germany
Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to the merger of the…
Address: Glienicker Weg 125 – 127
12489 Berlin ,Germany
Tel: +49 030-6707-0
Web: http://www.berlin-chemie.com/
BERLIN-CHEMIE is a German subsidiary of the MENARINI Group, which has been occupying a leading position in the Italian pharmaceutical market for many years. The company, which was formed in 1886 and is headquartered in Florence, was developed over the generations to become a global, owner-managed pharmaceutical company.MENARINI pursues two strategic objectives: research and internationalisation. Both endeavours enable innovative products to be used successfully to the satisfaction of patients throughout the world. The MENARINI Group enjoys an outstanding reputation worldwide as an efficient and reliable partner. This applies both to the development of new drugs and to the communication of scientific insights.
Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to the merger of the…
Cytonet is today Germany’s largest cell therapy enterprise. However, it went through many transformations since its spin-off from Roche Diagnostics in 2000. Could you briefly introduce the company to our…
The German Pharmaceutical Industry is not only known for its cutting-edge R&D and production base but also for having a high penetration of generics. In your opinion, what role do…
You have a wide experience in the pharmaceutical industry having worked for companies such as Amgen and Servier. What attracted you to Basilea? When I first considered moving to Basilea…
When we met Dr. Aleiotti in Italy, he said how important was Menarini´s acquisition of Berlin Chemie in the 1990s for the internationalization of the company in Eastern Europe and…
See our Cookie Privacy Policy Here
